Illumina Launches iSeq 100 Sequencing System

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today the launch of the iSeq™ 100 Sequencing System. The new, next-generation sequencing (NGS) system delivers exceptional data accuracy, at a low capital cost, making Illumina technology available to virtually any lab. The combination of the company’s proven sequencing by synthesis (SBS) chemistry, along with the complementary metal-oxide-semiconductor... Read more

MGI Genetic Sequencer Certified in New 10x Genomics Compatible Program

–MGI’s BGISEQ-500RS Genetic Sequencer, Forthcoming MGISEQ Genetic Sequencers Compatible with 10x Genomics Solutions– PLEASANTON, CA. and SHENZHEN, CHINA —January 8, 2018—10x Genomics, Inc. and MGI, a subsidiary of BGI, today announced that the BGISEQ-500RS genetic sequencer has met the rigorous standards of the new 10x Genomics Compatible Program. MGI will also ensure that the MGISEQ... Read more

QIAGEN adds to growth momentum in next-generation sequencing with 2018 plans for significant portfolio enhancements

Goal set to exceed $140 million of NGS-related sales in 2018, up from over $115 million in 2017 New Enterprise Genomics Services to offer gene panel customization capabilities to customers GeneReader NGS System plans include enhanced chemistry, more powerful gene panels Hilden, Germany, and Germantown, Maryland, January 8, 2018 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt... Read more

PerkinElmer to Hold Earnings Call on Thursday, January 25, 2018

WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced today announced that on Thursday, January 25, 2018, after market close, the Company will release fourth quarter 2017 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss... Read more

Illumina and KingMed Diagnostics Partner to Develop Next-Generation Sequencing Technology for Chinese FDA Approval

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.SS) today announced an agreement to jointly develop novel oncology and hereditary disease testing applications utilizing Illumina’s next-generation sequencing (NGS) technology. The collaboration is a significant step toward China Food and Drug Administration (CFDA) review and approval, and serves as a starting point to deliver... Read more

PRECIPIO LAUNCHES ITS SECOND NEW ICE-COLD PCR(TM) TARGETED ENRICHMENT KIT TO IDENTIFY MUTATIONS IN LUNG CANCER USING LIQUID (BLOOD) BIOPSIES ON SANGER SEQUENCING PLATFORMS

NEW HAVEN, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) — Precipio, Inc. (NASDAQ:PRPO), announced today the launch of the second new version of its ICE-COLD PCR™ (ICP) enrichment kit, used to identify resistance mutations in non-small cell lung cancer (NSCLC) using liquid biopsies. As part of the transformation of ICP to be platform-agnostic, this kit has... Read more

First Genomic Platform Powered by the Blockchain Raises $2 Million in Funding; Backed by Illumina Veterans

Luna DNA is the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community. SAN DIEGO, Dec. 18, 2017 /PRNewswire/ — Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced $2 Million in Seed funding today. The round included... Read more

New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes

New Myeloid Research Assay Combines Simultaneous DNA and RNA Analysis of Most Relevant Hematologic Cancer Driver Genes Oncomine Myeloid Research Assay leverages Thermo Fisher’s next-generation sequencing to analyze 74 genes in a single panel and overcome hurdles of sequential-based clinical research CARLSBAD, Calif., Dec. 7, 2017 /PRNewswire/ — Clinical researchers interested in studying driver mutations suspected... Read more

CMS Issues Proposed National Coverage Determination of NGS IVDs Including Thermo Fisher Scientific's Oncomine Dx Target Test

CMS Issues Proposed National Coverage Determination of NGS IVDs Including Thermo Fisher Scientific’s Oncomine Dx Target Test The proposed national coverage determination provides Medicare beneficiaries with reimbursable testing using multi-biomarker NGS IVD tests to better inform treatment decisions CARLSBAD, Calif., Dec. 7, 2017 /PRNewswire/ — The Centers for Medicare & Medicaid Services (CMS) has proposed coverage... Read more

New Salmonella Multiplex PCR Solution offers First Validated Assay for Simultaneous Detection of Three Salmonella Targets in One Rapid Test

New Salmonella Multiplex PCR Solution offers First Validated Assay for Simultaneous Detection of Three Salmonella Targets in One Rapid Test Real-Time PCR workflow gains AOAC-RI approval for rapid and simultaneous detection of Salmonella species, Salmonella Typhimurium and Salmonella Enteritidis BASINGSTOKE, England, Dec. 5, 2017 /PRNewswire/ — Poultry and pork producers can now rapidly screen for... Read more